New Insights into Renal Failure in a Cohort of 317 Patients with Autosomal Dominant Forms of Alport Syndrome: Report of Two Novel Heterozygous Mutations in COL4A3
Authors:
Open Access
- 19 August 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (16) , 4883
Abstract
Alport syndrome (AS) is a clinically and genetically heterogeneous disorder with a wide phenotypic spectrum, onset, and progression. X-linked AS (XLAS) and autosomal recessive AS (ARAS) are severe conditions, whereas the severity of autosomal dominant AS (ADAS) may vary from benign familial hematuria to progressive renal disease with extra-renal manifestations. In this study, we collated information from the literature and analyzed a cohort of 317 patients with ADAS carrying heterozygous disease-causing mutations in COL4A3/4 including four patients from two unrelated families who carried two novel variants in COL4A3. Regarding the age of onset of the disease, 80% of patients presented urinalysis alterations (microhematuria, hematuria, and/or proteinuria) before the age of 40 years. The cumulative probability of suffering adverse renal events was mainly observed between 30 and 70 years, without statistical differences between COL4A3 and COL4A4. We observed statistically significant differences between the sexes in the age of developing ESKD in cases affected by mutations in COL4A3/4 (p value = 0.0097), suggesting that males begin experiencing earlier deterioration of renal function than women. This study supports the importance of follow-up in young patients who harbor pathogenic mutations in COL4A3/4. We update the knowledge of ADAS, highlighting differences in the progression of the disease between males and females.Keywords
This publication has 38 references indexed in Scilit:
- Advances in Alport syndrome diagnosis using next-generation sequencingEuropean Journal of Human Genetics, 2011
- Novel heterozygous COL4A3 mutation in a family with late-onset ESRDPediatric Nephrology, 2010
- A Novel Mutation of COL4A3 Presents a Different Contribution to Alport Syndrome and Thin Basement Membrane NephropathyAmerican Journal of Nephrology, 2007
- Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuriaKidney International, 2007
- Autosomal-dominant Alport syndrome: Natural history of a disease due to COL4A3 or COL4A4 geneKidney International, 2004
- COL4A3/COL4A4 mutations: From familial hematuria to autosomal-dominant or recessive Alport syndromeKidney International, 2002
- Identification of a new mutation in the α4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemiaNephrology Dialysis Transplantation, 2001
- Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutationKidney International, 2000
- Glomerular Basement MembraneJournal of Biological Chemistry, 1998
- Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.Journal of Clinical Investigation, 1996